feed,title,long_url,short_url
Benzinga,Lower Vascepa Volume Hits Amarin's Q4 Topline Growth,https://benzinga.com/general/biotech/22/03/25897803/lower-vascepa-volume-hits-amarins-q4-topline-growth,https://bit.ly/3vv5md0
Benzinga,CTI BioPharma's Bone Marrow Cancer Drug Scores FDA Approval,https://benzinga.com/general/biotech/22/03/25897717/cti-biopharmas-bone-marrow-cancer-drug-scores-fda-approval,https://bit.ly/3Md0wHq
